06.17.26 -- Why Regulatory And Manufacturing Strategy Must Start Together

Transition from standalone equipment to integrated systems. Review critical protocols for a multi-layered strategy designed to successfully mitigate cumulative hazardous drug risks.

Clinical data review needs centralized access and traceable workflows. Leveraging AI-automation and real-time collaboration drives faster, better-informed decisions and reduced compliance risk.

Gain auditor insights into common compliance gaps. Learn practical, actionable methods to strengthen overall audit readiness and oversight in single institutional review board studies.

New FDA guidance aligns IND safety reports with unanticipated problems, shifting the focus from administrative definitions to proactive participant protection and trial integrity.

Modular production is moving from concept to reality. See how Module Type Package protocols enable flexible manufacturing and unlock valuable process data using real implementation examples.

As drug pipelines shift toward smaller, more complex therapies, portable bioprocessing tools are helping teams reduce delays, improve data integrity, and enable flexible manufacturing.

Regulators are implementing new rules to combat counterfeit medicines. Learn how serialization, tamper-evident seals, and track-and-trace solutions protect products and patients from risk.

Choosing the best sporicide for your cleanroom involves evaluating factors like surface format, contact time, and safety. Consider the criteria to select an effective and robust agent for contamination control.

Demystify the regulatory landscape for specialized therapies. Reconsider these five common myths that cell and gene therapy developers believe regarding regulatory expectations for orphan drugs.

True Annex 1 compliance requires a facility-wide contamination-control culture. Discover how rigorous risk awareness shapes behavior at every touchpoint across a manufacturing environment.

Evaluate packaging integrity and master wiping techniques to prevent cleanroom contamination. Focus on surface coverage and controlled transfer paths to ensure consistent product safety and quality.

Explore how Quality by Design strategies reduce regulatory burdens, simplify post-approval changes, and improve lifecycle flexibility while maintaining product quality and continuity.

The quality of non-active ingredients, or excipients, directly impacts product safety and efficacy. Uncover why Excipient GMP is vital for cell culture solutions and how it elevates manufacturing standards.